Invention Grant
- Patent Title: Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy
-
Application No.: US16537022Application Date: 2019-08-09
-
Publication No.: US11213575B2Publication Date: 2022-01-04
- Inventor: Marie-Luise Lubos , Alexander Schmidt , Christian Rueter
- Applicant: WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER
- Applicant Address: DE Muenster
- Assignee: WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER
- Current Assignee: WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER
- Current Assignee Address: DE Muenster
- Agency: Duane Morris LLP
- Agent Deborah L. Lu
- Priority: EP13185412 20130920
- Main IPC: A61K38/53
- IPC: A61K38/53 ; C07K14/25 ; C07K14/255 ; C12N9/00 ; A61K38/16
Abstract:
The present invention relates to cell-penetrating effector proteins of type III secretion system (T3SS)-containing bacteria of the genus Salmonella or Shigella and variants, fragments and immunomodulatory domains thereof, for use in immunotherapy. The present invention further relates to cell-penetrating effector proteins of type III secretion system (T3SS)-containing bacteria of the genus Salmonella or Shigella and variants, fragments and immunomodulatory domains thereof, for delivering cargo molecules into eukaryotic cells.
Public/Granted literature
- US20200038493A1 CELL-PENETRATING BACTERIAL E3-UBIQITIN-LIGASES FOR USE IN IMMUNOTHERAPY Public/Granted day:2020-02-06
Information query
IPC分类:
